Jared Kray, DO
Vascular Surgery · Cedar Rapids, IANPI 1932338837
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 33.2% of the total. Reporting peaked in 2021 at $3,300 and has fallen 84.1% since, to $524 in 2025.
Across 122 payments — averaging $71.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Cardiovascular Systems Inc.$1K
- Philips North America LLC$962
- Avinger Inc.$542
- Silk Road Medical, Inc.$452
- Abbott$394
- plus $2K from 21 others
What the payments were for
- Consulting fees$300%
- Speaking & faculty fees$1,95023%
- Travel & lodging$1,52118%
- Food & beverage$5,16560%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $2,877 |
| Cardiovascular Systems Inc. | 14 | $1,204 |
| Philips North America LLC | 8 | $962 |
| Avinger Inc. | 6 | $542 |
| Silk Road Medical, Inc. | 6 | $452 |
| Abbott | 9 | $394 |
| W. L. Gore & Associates, Inc. | 3 | $361 |
| Bolton Medical Inc | 4 | $264 |
| Angiodynamics, Inc. | 8 | $215 |
| Lemaitre Vascular, Inc. | 7 | $206 |
| Johnson & Johnson(2 entities) | 8 | $190 |
| Boston Scientific | 6 | $158 |
| Inari Medical, Inc. | 4 | $140 |
| Globus Medical | 1 | $125 |
| Shockwave Medical, Inc | 1 | $110 |
| Alphatec Spine, Inc | 1 | $95 |
| Stryker | 3 | $82 |
| Bard Peripheral Vascular, Inc. | 3 | $70 |
| Endologix LLC | 1 | $51 |
| Getinge USA Sales, LLC | 2 | $40 |
| Biocompatibles, Inc. | 1 | $22 |
| Penumbra, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $19 |
| Convatec Inc. | 1 | $19 |
| Surmodics, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Medela LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$1,950
- Peripheral Orbital Atherectomy System$863
- IGT D Peripheral$839
- ENROUTE Transcarotid Neuroprotection System$495
- PANTHERIS$416
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$248
- ENROUTE Transcarotid Stent$248
- HawkOne$176
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$142
- TREO ABDOMINAL STENT-GRAFT SYSTEM$142
- Hedron$125
- IN.PACT Admiral$116
- GORE EXCLUDER AAA Endoprosthesis$116
- Vascular Lithotripsy$110
- Coronary Orbital Atherectomy System$104
- EXCLUDER Iliac Branch Endoprosthesis$103
How this compares
$8,666 in reported general payments places this provider in the 70th percentile of 38 vascular surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 51 | $38,195 |
| Cilostazol | 69 | $1,162 |
| ClopidogrelClopidogrel Bisulfate | 65 | $692 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $190 | $38,19551 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 38 vascular surgery providers in Iowa.
Other vascular surgery in Cedar Rapids
- David LawrenceCedar Rapids$15K
- Nicole GensickeCedar Rapids$5K
- Kevin KopeskyCedar Rapids$76
- Douglas MassopWest Des Moines$590K
- Eric ScottWest Des Moines$393K
- David ChewWest Des Moines$43K
- James FosterIowa City$35K
- Nicholas SouthardWest Des Moines$27K
- Luigi PascarellaIowa City$16K
- Natalie WegerIowa City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.